These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
836 related items for PubMed ID: 25996366
21. Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007. Skowronski DM, De Serres G, Dickinson J, Petric M, Mak A, Fonseca K, Kwindt TL, Chan T, Bastien N, Charest H, Li Y. J Infect Dis; 2009 Jan 15; 199(2):168-79. PubMed ID: 19086914 [Abstract] [Full Text] [Related]
22. Low influenza vaccine effectiveness and the effect of previous vaccination in preventing admission with A(H1N1)pdm09 or B/Victoria-Lineage in patients 60 years old or older during the 2015/2016 influenza season. Puig-Barberà J, Guglieri-López B, Tortajada-Girbés M, López-Labrador FX, Carballido-Fernández M, Mollar-Maseres J, Schwarz-Chavarri G, Baselga-Moreno V, Mira-Iglesias A, Díez-Domingo J, Valencia Hospital Network for the Study of Influenza, Respiratory Viruses Disease. Vaccine; 2017 Dec 19; 35(52):7331-7338. PubMed ID: 29128380 [Abstract] [Full Text] [Related]
23. Influenza vaccine effectiveness against hospitalization with laboratory-confirmed influenza in Greece: A pooled analysis across six seasons, 2013-2014 to 2018-2019. Mouratidou E, Lambrou A, Andreopoulou A, Gioula G, Exindari M, Kossyvakis A, Pogka V, Mentis A, Georgakopoulou T, Lytras T. Vaccine; 2020 Mar 10; 38(12):2715-2724. PubMed ID: 32033848 [Abstract] [Full Text] [Related]
24. Seasonal influenza vaccine effectiveness against laboratory-confirmed influenza hospitalizations - Latin America, 2013. El Omeiri N, Azziz-Baumgartner E, Thompson MG, REVELAC-i network participants, Clará W, Cerpa M, Palekar R, Mirza S, Ropero-Álvarez AM. Vaccine; 2018 Jun 07; 36(24):3555-3566. PubMed ID: 28648543 [Abstract] [Full Text] [Related]
25. Estimating vaccine effectiveness in preventing laboratory-confirmed influenza in outpatient settings in South Africa, 2015. McAnerney JM, Walaza S, Tempia S, Blumberg L, Treurnicht FK, Madhi SA, Valley-Omar Z, Cohen C. Influenza Other Respir Viruses; 2017 Mar 07; 11(2):177-181. PubMed ID: 27865064 [Abstract] [Full Text] [Related]
26. 2015/16 I-MOVE/I-MOVE+ multicentre case-control study in Europe: Moderate vaccine effectiveness estimates against influenza A(H1N1)pdm09 and low estimates against lineage-mismatched influenza B among children. Kissling E, Valenciano M, Pozo F, Vilcu AM, Reuss A, Rizzo C, Larrauri A, Horváth JK, Brytting M, Domegan L, Korczyńska M, Meijer A, Machado A, Ivanciuc A, Višekruna Vučina V, van der Werf S, Schweiger B, Bella A, Gherasim A, Ferenczi A, Zakikhany K, O Donnell J, Paradowska-Stankiewicz I, Dijkstra F, Guiomar R, Lazar M, Kurečić Filipović S, Johansen K, Moren A, I-MOVE/I-MOVE+ study team. Influenza Other Respir Viruses; 2018 Jul 07; 12(4):423-437. PubMed ID: 29125681 [Abstract] [Full Text] [Related]
27. Influenza vaccine effectiveness in preventing outpatient, inpatient, and severe cases of laboratory-confirmed influenza. Castilla J, Godoy P, Domínguez A, Martínez-Baz I, Astray J, Martín V, Delgado-Rodríguez M, Baricot M, Soldevila N, Mayoral JM, Quintana JM, Galán JC, Castro A, González-Candelas F, Garín O, Saez M, Tamames S, Pumarola T, CIBERESP Cases and Controls in Influenza Working Group Spain. Clin Infect Dis; 2013 Jul 07; 57(2):167-75. PubMed ID: 23532475 [Abstract] [Full Text] [Related]
28. Influenza vaccine effectiveness against medically-attended influenza illness during the 2012-2013 season in Beijing, China. Yang P, Thompson MG, Ma C, Shi W, Wu S, Zhang D, Wang Q. Vaccine; 2014 Sep 15; 32(41):5285-9. PubMed ID: 25092635 [Abstract] [Full Text] [Related]
29. 2012/13 influenza vaccine effectiveness against hospitalised influenza A(H1N1)pdm09, A(H3N2) and B: estimates from a European network of hospitals. Rondy M, Launay O, Puig-Barberà J, Gefenaite G, Castilla J, de Gaetano Donati K, Galtier F, Hak E, Guevara M, Costanzo S, European hospital IVE network, Moren A. Euro Surveill; 2015 Jan 15; 20(2):. PubMed ID: 25613779 [Abstract] [Full Text] [Related]
30. Pooled influenza vaccine effectiveness estimates for Australia, 2012-2014. Sullivan SG, Carville KS, Chilver M, Fielding JE, Grant KA, Kelly H, Levy A, Stocks NP, Tempone SS, Regan AK. Epidemiol Infect; 2016 Aug 15; 144(11):2317-28. PubMed ID: 27125368 [Abstract] [Full Text] [Related]
31. Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada. Skowronski DM, Masaro C, Kwindt TL, Mak A, Petric M, Li Y, Sebastian R, Chong M, Tam T, De Serres G. Vaccine; 2007 Apr 12; 25(15):2842-51. PubMed ID: 17081662 [Abstract] [Full Text] [Related]
32. Influenza vaccine effectiveness among outpatients in the US Influenza Vaccine Effectiveness Network by study site 2011-2016. Balasubramani GK, Nowalk MP, Sax TM, Suyama J, Bobyock E, Rinaldo CR, Martin ET, Monto AS, Jackson ML, Gaglani MJ, Flannery B, Chung JR, Zimmerman RK. Influenza Other Respir Viruses; 2020 Jul 12; 14(4):380-390. PubMed ID: 32298048 [Abstract] [Full Text] [Related]
33. Effectiveness of seasonal influenza vaccine for adults and children in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 end-of-season results. Pebody R, Warburton F, Ellis J, Andrews N, Potts A, Cottrell S, Johnston J, Reynolds A, Gunson R, Thompson C, Galiano M, Robertson C, Byford R, Gallagher N, Sinnathamby M, Yonova I, Pathirannehelage S, Donati M, Moore C, de Lusignan S, McMenamin J, Zambon M. Euro Surveill; 2016 Sep 22; 21(38):. PubMed ID: 27684603 [Abstract] [Full Text] [Related]
34. Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015-2016 Season in Canada. Skowronski DM, Chambers C, Sabaiduc S, De Serres G, Winter AL, Dickinson JA, Gubbay JB, Drews SJ, Martineau C, Charest H, Krajden M, Bastien N, Li Y. J Infect Dis; 2017 Dec 19; 216(12):1487-1500. PubMed ID: 29029166 [Abstract] [Full Text] [Related]
35. Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine. Skowronski DM, Janjua NZ, Sabaiduc S, De Serres G, Winter AL, Gubbay JB, Dickinson JA, Fonseca K, Charest H, Bastien N, Li Y, Kwindt TL, Mahmud SM, Van Caeseele P, Krajden M, Petric M. J Infect Dis; 2014 Jul 01; 210(1):126-37. PubMed ID: 24446529 [Abstract] [Full Text] [Related]
36. Repeated Vaccination Does Not Appear to Impact Upon Influenza Vaccine Effectiveness Against Hospitalization With Confirmed Influenza. Cheng AC, Macartney KK, Waterer GW, Kotsimbos T, Kelly PM, Blyth CC, Influenza Complications Alert Network (FluCAN) Investigators. Clin Infect Dis; 2017 Jun 01; 64(11):1564-1572. PubMed ID: 28329167 [Abstract] [Full Text] [Related]
37. Effectiveness of the 2010-11 seasonal trivalent influenza vaccine in Spain: cycEVA study. Jiménez-Jorge S, Savulescu C, Pozo F, de Mateo S, Casas I, Ledesma J, Larrauri A, cycEVA Study Team, Spanish Influenza Sentinel Surveillance System. Vaccine; 2012 May 21; 30(24):3595-602. PubMed ID: 22472792 [Abstract] [Full Text] [Related]
38. Long term effectiveness of adjuvanted influenza A(H1N1)pdm09 vaccine in children. Örtqvist Å, Bennet R, Hamrin J, Rinder MR, Lindblad H, Öhd JN, Eriksson M. Vaccine; 2015 May 21; 33(22):2558-61. PubMed ID: 25869891 [Abstract] [Full Text] [Related]
39. Effectiveness of influenza vaccine against laboratory-confirmed influenza, in the late 2011-2012 season in Spain, among population targeted for vaccination. Jiménez-Jorge S, de Mateo S, Delgado-Sanz C, Pozo F, Casas I, Garcia-Cenoz M, Castilla J, Pérez E, Gallardo V, Rodriguez C, Vega T, Quiñones C, Martínez E, Vanrell JM, Giménez J, Castrillejo D, Serrano Mdel C, Ramos JM, Larrauri A, Spanish Influenza Sentinel Surveillance System. BMC Infect Dis; 2013 Sep 22; 13():441. PubMed ID: 24053661 [Abstract] [Full Text] [Related]